Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas J Adams

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Nature Communications|May 13, 2021
INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replicationUpdesh Dixit, Savita Bhutoria, Xuhong Wu, et al.
Lupus Science & Medicine|March 14, 2018
Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosusJoseph M Kheir, Carla J Guthridge, Jonathon R Johnston, et al.
Cell Reports|July 21, 2021
An intranasal vaccine durably protects against SARS-CoV-2 variants in miceAhmed O Hassan, Swathi Shrihari, Matthew J Gorman, et al.
Cell Host & Microbe|August 18, 2020
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in MiceJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
Cell|October 7, 2023
Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8Ofer Zimmerman, Maxwell I Zimmerman, Saravanan Raju, et al.
Cell Host & Microbe|November 19, 2024
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in miceJames Brett Case, Shilpa Sanapala, Carly Dillen, et al.
JCI Insight|January 4, 2024
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activityOfer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
Cell Reports. Medicine|June 10, 2022
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromesOfer Zimmerman, Alexa Michelle Altman Doss, Paulina Kaplonek, et al.
Frontiers in Immunology|January 9, 2023
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patientsFrank J Lin, Alexa Michelle Altman Doss, Hannah G Davis-Adams, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Nature Communications|May 13, 2021
INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replicationUpdesh Dixit, Savita Bhutoria, Xuhong Wu, et al.
Lupus Science & Medicine|March 14, 2018
Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosusJoseph M Kheir, Carla J Guthridge, Jonathon R Johnston, et al.
Cell Reports|July 21, 2021
An intranasal vaccine durably protects against SARS-CoV-2 variants in miceAhmed O Hassan, Swathi Shrihari, Matthew J Gorman, et al.
Cell Host & Microbe|August 18, 2020
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in MiceJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Immunity|September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitopeLaura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
Cell|October 7, 2023
Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8Ofer Zimmerman, Maxwell I Zimmerman, Saravanan Raju, et al.
Cell Host & Microbe|November 19, 2024
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in miceJames Brett Case, Shilpa Sanapala, Carly Dillen, et al.
JCI Insight|January 4, 2024
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activityOfer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
Cell Reports. Medicine|June 10, 2022
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromesOfer Zimmerman, Alexa Michelle Altman Doss, Paulina Kaplonek, et al.
Frontiers in Immunology|January 9, 2023
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patientsFrank J Lin, Alexa Michelle Altman Doss, Hannah G Davis-Adams, et al.
Pageof 4